PCK 0.00% 2.9¢ painchek ltd

I don't really understand those with high revenue expectations...

  1. 330 Posts.
    lightbulb Created with Sketch. 57
    I don't really understand those with high revenue expectations at this stage. PCK has been very transparent and didn't pump the market with fluff. Seriously, only an idiot would of expected anything more than double, especially prior to gov deal.

    PCK is in rapid expansion mode. The business is building on all fronts to achieve sustainable long term revenues and operation.

    The best thing to do is sign up the biggest possible amount of customers (even at lower revenues for all I care), build the clinical justification and expertise here in Australia. Then use that as your selling point internationally, across other markets and segments. When we achieve gold standard in industry, customers/governments will come to us.

    The short term sentiment here deserved today IMO.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.